Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
July 24, 2020
Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model
Soha A Hassan, Christian Schmithals, Maike von Harten, et al.
Biochimica Et Biophysica Acta
|
July 6, 2015
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Judith W J Bergs, Matthias G Wacker, Stephanie Hehlgans, et al.
Oncogene
|
January 16, 2003
Tumor regression by combination antisense therapy against Plk1 and Bcl-2
Robert Elez, Albrecht Piiper, Bernd Kronenberger, et al.
Biochemical and Biophysical Research Communications
|
February 19, 2003
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor
Albrecht Piiper, Manfred P Lutz, Henning Cramer, et al.
Antiviral Therapy
|
August 24, 2007
Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C
Bernd Kronenberger, Stefan Zeuzem, Christoph Sarrazin, et al.
The Journal of Biological Chemistry
|
October 6, 2009
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products
Oliver Waidmann, Thomas Pleli, Karel Dvorak, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
March 16, 2012
Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience
Huedayi Korkusuz, Lea Knau, Wolfgang Kromen, et al.
Translational Oncology
|
June 5, 2013
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Dominik Bergis, Valentin Kassis, Annika Ranglack, et al.
Plos One
|
February 23, 2012
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity
Martin-Walter Welker, David Reichert, Simone Susser, et al.
Plos One
|
February 16, 2018
Selective targeting of tumor associated macrophages in different tumor models
Bianca Kakoschky, Thomas Pleli, Christian Schmithals, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
July 24, 2020
Time-dependent changes in proliferation, DNA damage and clock gene expression in hepatocellular carcinoma and healthy liver of a transgenic mouse model
Soha A Hassan, Christian Schmithals, Maike von Harten, et al.
Biochimica Et Biophysica Acta
|
July 6, 2015
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Judith W J Bergs, Matthias G Wacker, Stephanie Hehlgans, et al.
Oncogene
|
January 16, 2003
Tumor regression by combination antisense therapy against Plk1 and Bcl-2
Robert Elez, Albrecht Piiper, Bernd Kronenberger, et al.
Biochemical and Biophysical Research Communications
|
February 19, 2003
Protein kinase A mediates cAMP-induced tyrosine phosphorylation of the epidermal growth factor receptor
Albrecht Piiper, Manfred P Lutz, Henning Cramer, et al.
Antiviral Therapy
|
August 24, 2007
Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C
Bernd Kronenberger, Stefan Zeuzem, Christoph Sarrazin, et al.
The Journal of Biological Chemistry
|
October 6, 2009
Inhibition of the equilibrative nucleoside transporter 1 and activation of A2A adenosine receptors by 8-(4-chlorophenylthio)-modified cAMP analogs and their hydrolytic products
Oliver Waidmann, Thomas Pleli, Karel Dvorak, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
March 16, 2012
Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience
Huedayi Korkusuz, Lea Knau, Wolfgang Kromen, et al.
Translational Oncology
|
June 5, 2013
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Dominik Bergis, Valentin Kassis, Annika Ranglack, et al.
Plos One
|
February 23, 2012
Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity
Martin-Walter Welker, David Reichert, Simone Susser, et al.
Plos One
|
February 16, 2018
Selective targeting of tumor associated macrophages in different tumor models
Bianca Kakoschky, Thomas Pleli, Christian Schmithals, et al.
Page
of 8